{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T02:36:10Z","timestamp":1775702170701,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"No funding","award":["No funding"],"award-info":[{"award-number":["No funding"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40644-017-0108-6","type":"journal-article","created":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T08:11:46Z","timestamp":1486368706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["DEB TACE for Intermediate and advanced HCC \u2013 Initial Experience in a Brazilian Cancer Center"],"prefix":"10.1186","volume":"17","author":[{"given":"Jose Hugo Mendes","family":"Luz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula M.","family":"Luz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique S.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo R.","family":"Gouveia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphal Braz","family":"Levigard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe Diniz","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo Caetano","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago Nepomuceno","family":"de Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Henrique","family":"Mamede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,6]]},"reference":[{"key":"108_CR1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2007-1007117","volume":"19","author":"FX Bosch","year":"1999","unstructured":"Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19:271\u201385.","journal-title":"Semin Liver Dis"},{"key":"108_CR2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378\u201390.","journal-title":"N Engl J Med"},{"key":"108_CR3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0030-1247133","volume":"30","author":"A Forner","year":"2010","unstructured":"Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30:61\u201374.","journal-title":"Semin Liver Dis"},{"issue":"3","key":"108_CR4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an up-date. Hepatology. 2011;53(3):1020\u20132.","journal-title":"Hepatology"},{"issue":"3","key":"108_CR5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","volume":"35","author":"J Bruix","year":"2001","unstructured":"Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35(3):421\u201330.","journal-title":"J Hepatol"},{"key":"108_CR6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.RVI.0000195323.46152.B3","volume":"17","author":"AL Lewis","year":"2006","unstructured":"Lewis AL, Gonzalez MV, Lloyd AW, et al. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol. 2006;17:335\u201342.","journal-title":"J Vasc Interv Radiol"},{"key":"108_CR7","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1158\/1078-0432.CCR-05-2225","volume":"12","author":"K Hong","year":"2006","unstructured":"Hong K, Khwaja A, Liapi E, et al. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res. 2006;12:2563\u20137.","journal-title":"Clin Cancer Res"},{"key":"108_CR8","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00270-010-9794-1","volume":"33","author":"KH Lee","year":"2010","unstructured":"Lee KH, Liapi EA, Cornell C, et al. Doxorubicin-loaded QuadraSphere microspheres: plasma pharmacokinetics and in- tratumoral drug concentration in an animal model of liver cancer. Cardiovasc Intervent Radiol 2010 33:576\u201382.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"108_CR9","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jvir.2010.02.042","volume":"21","author":"O Jordan","year":"2010","unstructured":"Jordan O, Denys A, De Baere T, Boulens N, Doelker E. Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan. J Vasc Interv Radiol. 2010;21:1084\u201390.","journal-title":"J Vasc Interv Radiol"},{"key":"108_CR10","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","volume":"46","author":"M Varela","year":"2007","unstructured":"Varela M, Real MI, Burrel M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol. 2007;46:474\u201381.","journal-title":"J Hepatol"},{"issue":"6","key":"108_CR11","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jhep.2012.01.008","volume":"56","author":"M Burrel","year":"2012","unstructured":"Burrel M, Reig M, Forner A et al. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design. J Hepat. 2012;56(6):1330\u201335.","journal-title":"J Hepat"},{"issue":"113","key":"108_CR12","first-page":"255","volume":"59","author":"R Martin","year":"2012","unstructured":"Martin R, Geller D, Espat J et al. Safety and efficacy of transarterial chemoembolization with drug-eluting beads in hepatocellular cancer: a systematic review. Hepatogastroenterology. 2012;59(113):255\u201360.","journal-title":"Hepatogastroenterology"},{"key":"108_CR13","first-page":"150667","volume":"8","author":"JF Geschwind","year":"2016","unstructured":"Geschwind JF, Kudo M, Marrero JA, Venook AP, Chen XP, Bronowicki JP, et al. TACE treatment in patients with sorafenib treated unresectable hepatocellular carcinoma in clinical practice: final analysis of GIDEON. Radiology. 2016;8:150667 [Epub ahead of print].","journal-title":"Radiology"},{"key":"108_CR14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","volume":"33","author":"J Lammer","year":"2010","unstructured":"Lammer J, Malagari K, Vogl T, et al. Prospective randomised study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2010;33:41\u201352.","journal-title":"Cardiovasc Intervent Radiol."},{"key":"108_CR15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM. Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma. Semin Liver Dis. 2010;30:52\u201360.","journal-title":"Semin Liver Dis"},{"key":"108_CR16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1051-0443(07)61377-3","volume":"11","author":"NH Patel","year":"2000","unstructured":"Patel NH, Hahn D, Rapp S, et al. Hepatic artery embolization: factors predisposing to postembolization pain and nausea. J Vasc Interv Radiol. 2000;11:453\u201360.","journal-title":"J Vasc Interv Radiol"},{"issue":"2 Pt 1","key":"108_CR17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.RVI.0000196277.76812.A3","volume":"17","author":"DB Brown","year":"2006","unstructured":"Brown DB, Geschwind JF, Soulen MC, et al. Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies. J Vasc Interv Radiol. 2006;17(2 Pt 1):217\u201323.","journal-title":"J Vasc Interv Radiol"},{"key":"108_CR18","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s10856-007-3068-8","volume":"18","author":"AL Lewis","year":"2007","unstructured":"Lewis AL, Gonzalez MV, Leppard SW, et al. Doxorubicin eluting beads\u20131: effects of drug loading on bead characteristics and drug distribution. J Mater Sci Mater Med. 2007;18:1691\u20139.","journal-title":"J Mater Sci Mater Med"},{"key":"108_CR19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1148\/radiology.198.1.8539401","volume":"198","author":"JW Chung","year":"1996","unstructured":"Chung JW, Park JH, Han JK, et al. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology. 1996;198:33\u201340.","journal-title":"Radiology"},{"key":"108_CR20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1051-0443(07)61911-3","volume":"12","author":"DA Leung","year":"2001","unstructured":"Leung DA, Goin JE, Sickles C, et al. Determinants of postembolization syndrome after hepatic chemoembolization. J Vasc Interv Radiol. 2001;12:321\u20136.","journal-title":"J Vasc Interv Radiol"},{"key":"108_CR21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jjco\/hyg093","volume":"33","author":"OP Joon","year":"2003","unstructured":"Joon OP, Lee SI, Song SY, et al. Measuring response in solid tumors: comparison of RECIST and WHO response criteria. Jpn J Clin Oncol. 2003;33:533\u20137.","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"108_CR22","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2011.04.028","volume":"56","author":"H Shim","year":"2012","unstructured":"Shim H, Lee H, Won H, et al. Maximum number of target lesions required to measure responses to transarterial chemoembolization using the enhancement criteria in patients with intrahepatic hepatocellular carcinoma. J Hepatol. 2012;56(2):406\u201311.","journal-title":"J Hepatol"},{"key":"108_CR23","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S1051-0443(07)61299-8","volume":"11","author":"JF Geschwind","year":"2000","unstructured":"Geschwind JF, Artemov D, Abraham S, et al. Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion- weighted MR imaging and histologic analysis. J Vasc Interv Radiol. 2000;11:1245\u201355.","journal-title":"J Vasc Interv Radiol"},{"key":"108_CR24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/jjco\/hyf097","volume":"32","author":"M Ikeda","year":"2002","unstructured":"Ikeda M, Okada S, Yamamoto S, et al. Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization. Jpn J Clin Oncol. 2002;32:455\u201360.","journal-title":"Jpn J Clin Oncol"},{"key":"108_CR25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<50::AID-CNCR8>3.0.CO;2-I","volume":"88","author":"L Llado","year":"2000","unstructured":"Llado L, Virgili J, Figueras J, et al. A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Cancer. 2000;88:50\u20137.","journal-title":"Cancer"},{"issue":"4","key":"108_CR26","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1007\/s12032-011-0145-0","volume":"29","author":"ZJ Niu","year":"2012","unstructured":"Niu ZJ, Ma YL, Kang P, et al. Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification. Med Oncol. 2012;29(4):2992\u20137.","journal-title":"Med Oncol"},{"key":"108_CR27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1756-9966-29-164","volume":"29","author":"M Scartozzi","year":"2010","unstructured":"Scartozzi M, Baroni GS, Faloppi L, et al. Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis. J Exp Clin Cancer Res. 2010;29:164.","journal-title":"J Exp Clin Cancer Res"},{"key":"108_CR28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40644-015-0043-3","volume":"15","author":"F Duan","year":"2015","unstructured":"Duan F, Yu W, Wang Y, et al. Trans-arterial chemoembolization and external beam radiation therapy for treatment of hepatocellular carcinoma with a tumor thrombus in the inferior vena cava and right atrium. Cancer Imaging. 2015;15:7.","journal-title":"Cancer Imaging"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-017-0108-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T05:52:41Z","timestamp":1498369961000},"score":1,"resource":{"primary":{"URL":"http:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-017-0108-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,6]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["108"],"URL":"https:\/\/doi.org\/10.1186\/s40644-017-0108-6","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,6]]},"article-number":"5"}}